Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 8-K Event Results of operations
  2. ARS Other Annual Report to Security Holders
  3. DEF 14A Proxy Proxy Statement
  4. 4 Insider Changes in Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 10-K Report Annual Report
  7. 8-K Event Results of operations
  8. 8-K Event Other events
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4/A Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 8-K Event Executive or director change
  20. EFFECT Other Notice of Effectiveness

Page 2 of 14 · 267 filings